Compare AVIR & ONTF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AVIR | ONTF |
|---|---|---|
| Founded | 2012 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 318.0M | 341.1M |
| IPO Year | 2020 | 2021 |
| Metric | AVIR | ONTF |
|---|---|---|
| Price | $6.08 | $8.03 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 2 | 2 |
| Target Price | $8.00 | ★ $8.10 |
| AVG Volume (30 Days) | ★ 569.0K | 506.6K |
| Earning Date | 06-01-2026 | 05-28-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 3.00 | ★ 12.93 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $351,367,000.00 | $148,081,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $1.51 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $2.46 | $4.35 |
| 52 Week High | $6.45 | $8.10 |
| Indicator | AVIR | ONTF |
|---|---|---|
| Relative Strength Index (RSI) | 76.99 | 63.04 |
| Support Level | $3.33 | $7.84 |
| Resistance Level | N/A | $8.09 |
| Average True Range (ATR) | 0.31 | 0.04 |
| MACD | 0.12 | -0.02 |
| Stochastic Oscillator | 79.43 | 67.65 |
Atea Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on discovering, developing, and commercializing antiviral therapeutics to improve the lives of patients suffering from serious viral infections. The company is developing its product candidate, bemnifosbuvir, for the treatment of COVID-19, the disease caused by infection with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and its variants and also developing bemnifosbuvir in combination with ruzasvir for the treatment of Hepatitis C (HCV).
ON24 Inc provides a cloud-based intelligent engagement platform that combines experiences with personalization and content, to enable sales and marketing organizations to capture and act on connected insights at scale. The Company's platform offers a portfolio of interactive and hyper-personalized digital experience products that create and capture actionable, real-time data at scale from millions of professionals to provide businesses with buying signals and behavioral insights to efficiently convert prospects into customers. It provides solutions to Financial services, Life Sciences, Life sciences, Insurance, Technology, Associations, and Others.